We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Phytochemicals in Olive Oil Suppress Growth of Breast Cancer Cells

By LabMedica International staff writers
Posted on 30 Dec 2008
Spanish cancer researchers have found that the phytochemical components of extra-virgin olive oil repress the HER2/neu cancer oncogene and can effectively suppress growth of breast cancer cells overexpressing this gene.

Approximately 15-20% of breast cancers have an amplification of the HER2/neu gene or overexpression of its protein product. More...
Overexpression of this receptor in breast cancer is associated with increased disease recurrence and worse prognosis. The acronym HER2/neu (also known as ErbB-2) stands for human epidermal growth factor receptor 2, which is a member of the ErbB protein family, more commonly known as the epidermal growth factor receptor family.

Researchers in biomedical fields as diverse as cardiovascular diseases, autoimmune diseases, and cancer are seeking the molecular basis for the health benefits imparted by the "Mediterranean diet,” which is highly enriched with olive oil. In the current study, investigators from the Catalan Institute of Oncology (Spain) and the University of Granada (Spain) studied the effect of various components of extra-virgin olive oil (EVOO) on breast cancer. Since extra-virgin olive oil is obtained by pressing olives without the use of heat or chemical treatments, it contains phytochemicals that are otherwise lost in the refining process.

The investigators used solid phase extraction followed by semi-preparative high-performance liquid chromatography (HPLC) to isolate phenolic fractions from commercial EVOO. Analytic capillary electrophoresis coupled to mass spectrometry was performed to confirm the identity of the isolated fractions.

EVOO polyphenolic fractions were tested for their tumoricidal ability against HER2-negative and HER2-positive breast cancer cells growing in tissue culture using various chemical and immunological methods. Results presented in the December 18, 2008, online edition of the journal BMC Cancer revealed that all the major complex phenols present in extra-virgin olive oil drastically suppressed overexpression of the cancer gene HER2 in human breast cancer cells.

While this finding is of considerable interest in its own right, the investigators did caution that, "The active phytochemicals [i.e., lignans and secoiridoids] exhibited tumoricidal effects against cultured breast cancer cells at concentrations that are unlikely to be achieved in real life by consuming olive oil.” This fact notwithstanding, they went on to report that, "These findings, together with the fact that that humans have safely been ingesting significant amounts of lignans and secoiridoids as long as they have been consuming olives and extra-virgin oil, strongly suggest that these polyphenols might provide an excellent and safe platform for the design of new anti breast-cancer drugs.”

Related Links:
Catalan Institute of Oncology
University of Granada


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.